Prostatis Group’s Vanguard Intermediate-Term Corporate Bond ETF VCIT Stock Holding History

Prostatis Group’s Portfolio VCIT Stock Details VCIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Sell	2,821 -42,172	-94%	-$3.49M	0.05%	165
2026 Q1	$3.72M	Buy	44,993 +19,280	+75%	+$1.61M	0.95%	28
2025 Q4	$2.15M	Buy	+25,713	New	+$2.16M	0.51%	46
2020 Q4	–	Sell	-30,887	Closed	-$2.96M	–	88
2020 Q3	$2.96M	Buy	+30,887	New	+$2.97M	2.8%	10

Other funds holding VCIT

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Prostatis Group's VCIT Position: Q2 2026 in Review

Prostatis Group reduced its Vanguard Intermediate-Term Corporate Bond ETF (VCIT) stake by 94% in Q2 2026, selling an estimated $3.49M and leaving 2,821 shares worth $233K. The position accounts for 0.05% of the portfolio, ranked #165.

Prostatis Group first reported a position in VCIT in Q3 2020 and has held it in 4 quarters since. The position peaked at $3.72M in Q1 2026. 1,354 funds tracked by Wall St. Rank hold VCIT as of Q2 2026.

Prostatis Group held 2,821 shares of Vanguard Intermediate-Term Corporate Bond ETF worth $233K as of Q2 2026.
Prostatis Group sold 42,172 Vanguard Intermediate-Term Corporate Bond ETF shares in Q2 2026, an estimated $3.49M.
Vanguard Intermediate-Term Corporate Bond ETF made up 0.05% of Prostatis Group's portfolio in Q2 2026, its #165 holding.
Prostatis Group first reported a position in Vanguard Intermediate-Term Corporate Bond ETF in Q3 2020 and has held it in 4 quarters since.
Prostatis Group's Vanguard Intermediate-Term Corporate Bond ETF position peaked at $3.72M in Q1 2026.
1,354 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Corporate Bond ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.